Expand BHC Menu
BHC MENU

BHC Latest Press Releases

-- December 23, 2025 --

Bausch Health Announces Final Results and Expiration of Exchange Offers ACCESS Newswire 5:35 PM

-- December 8, 2025 --

Bausch Health Announces Early Exchange Offer Results for Exchange Offers ACCESS Newswire 7:23 PM

-- December 1, 2025 --

Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China ACCESS Newswire 7:00 AM

-- November 24, 2025 --

Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes ACCESS Newswire 7:05 AM

-- November 18, 2025 --

Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference ACCESS Newswire 7:00 AM

-- November 5, 2025 --

Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease ACCESS Newswire 8:00 AM

-- October 29, 2025 --

Bausch Health Announces Third Quarter 2025 Results ACCESS Newswire 4:05 PM

-- October 9, 2025 --

Bausch Health Announces Results of Special Meeting of Shareholders ACCESS Newswire 7:00 AM

-- September 30, 2025 --

Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV ACCESS Newswire 8:00 AM
Bausch Health to Announce Third Quarter 2025 Results on October 29 ACCESS Newswire 7:00 AM

-- September 29, 2025 --

Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry ACCESS Newswire 8:00 AM

-- September 11, 2025 --

Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio ACCESS Newswire 8:35 AM

-- September 5, 2025 --

Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System ACCESS Newswire 8:02 AM

-- August 26, 2025 --

Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025 ACCESS Newswire 8:00 AM

-- August 21, 2025 --

Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan ACCESS Newswire 8:02 AM

-- August 15, 2025 --

Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes ACCESS Newswire 2:30 PM

-- August 7, 2025 --

Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners ACCESS Newswire 8:00 AM

-- July 30, 2025 --

Bausch Health Announces Second Quarter 2025 Results ACCESS Newswire 4:05 PM

-- July 29, 2025 --

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease ACCESS Newswire 7:00 AM

-- July 28, 2025 --

Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand ACCESS Newswire 9:10 AM
Market Data Delayed 15 Minutes